Our Mission Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Our team works with patients and advocacy organizations to better understand their journey and raise awareness of the unmet need our programs seek to address. We collaborate with top-tier academic and medical institutions, scientific thought leaders, and clinical key opinion leaders in developing the first generation of targeted therapies focusing on mitochondrial dysfunction as it presents in these rare genetic diseases and common diseases of aging. With these collaborative efforts, we continue to advance our platform of late-stage clinical programs and novel pipeline candidates. Please be aware of the potential for scams claiming to represent Stealth BioTherapeutics in recruitment activities. Stealth exclusively uses @stealthbt.com e-mail addresses for recruitment purposes and does not conduct interviews via social media or other third-party sites. Please report any suspicious recruiting activity to us at careers@stealthbt.com and to the Internet Crime Complaint Center.
View Top Employees from Stealth BioTherapeuticsWebsite | http://www.stealthbt.com/ |
Ticker | MITO |
Revenue | $12.8 million |
Funding | $58.5 million |
Employees | 63 (63 on RocketReach) |
Founded | 2007 |
Address | 123 Highland Ave Suite 201, Needham, Massachusetts 02494, US |
Phone | (617) 600-6888 |
Technologies |
JavaScript,
HTML,
PHP
+17 more
(view full list)
|
Industry | Biotechnology, Drug Manufacturing & Research, Biopharma, Pharmaceuticals, Healthcare, Health Care, Science and Engineering, Pharmaceutical, Therapeutics |
Web Rank | 3 Million |
Keywords | Stealth Biotherapeutics, Companies In Auburndale Ma, Stealth Bio, Stealth Biotherapeutics Inc., Elamipretide Stealth |
Competitors | Curemark, LLC, CymaBay Therapeutics, GlycoMimetics, Leap Therapeutics, Visterra Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 541 Companies |
Looking for a particular Stealth BioTherapeutics employee's phone or email?
The Stealth BioTherapeutics annual revenue was $12.8 million in 2024.
Mike Malynn is the Chief People Officer of Stealth BioTherapeutics.
63 people are employed at Stealth BioTherapeutics.
Stealth BioTherapeutics is based in Needham, Massachusetts.
The NAICS codes for Stealth BioTherapeutics are [32541, 3254, 54, 32, 325, 541].
The SIC codes for Stealth BioTherapeutics are [28, 283].